Literature DB >> 14783086

The use of control charts in the clinical laboratory.

S LEVEY, E R JENNINGS.   

Abstract

Keywords:  LABORATORIES

Mesh：

Year:  1950        PMID： 14783086     DOI： 10.1093/ajcp/20.11_ts.1059

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN： 0002-9173            Impact factor:   2.493


× No keyword cloud information.
  43 in total

1.  Optimization of a human papillomavirus-specific enzyme-linked immunosorbent assay.

Authors:  Kevin L Karem; Alysia C Poon; Cynthia Bierl; Rosane Nisenbaum; Elizabeth Unger
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

2.  A Root Cause Analysis Into the High Error Rate in Clinical Immunohistochemistry.

Authors:  Steven A Bogen
Journal:  Appl Immunohistochem Mol Morphol       Date:  2019-02-22

3.  The running of standards in clinical chemistry and the use of the control chart.

Authors:  R J HENRY; M SEGALOVE
Journal:  J Clin Pathol       Date:  1952-11       Impact factor: 3.411

4.  Walter A Shewhart, 1924, and the Hawthorne factory.

Authors:  M Best; D Neuhauser
Journal:  Qual Saf Health Care       Date:  2006-04

5.  [Ultramicromethods in clinical laboratories. II. Determination of reliability of laboratory methods].

Authors:  R RICHTERICH; J P COLOMBO
Journal:  Klin Wochenschr       Date:  1962-05-15

6.  External quality assurance programme for enzymatic analysis of lysosomal storage diseases: a pilot study.

Authors:  G J G Ruijter; M Boer; C W Weykamp; R de Vries; I van den Berg; J Janssens-Puister; K Niezen-Koning; R A Wevers; B J H M Poorthuis; O P van Diggelen
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

7.  Application of traditional clinical pathology quality control techniques to molecular pathology.

Authors:  Shu-Ling Liang; Ming-Tseh Lin; Michael J Hafez; Christopher D Gocke; Kathleen M Murphy; Lori J Sokoll; James R Eshleman
Journal:  J Mol Diagn       Date:  2008-02-07       Impact factor: 5.568

Review 8.  Validation of bioanalytical methods.

Authors:  H T Karnes; G Shiu; V P Shah
Journal:  Pharm Res       Date:  1991-04       Impact factor: 4.200

9.  Quality Control in Clinical Chemistry: Minimal Requirements for an Acceptable Program.

Authors:  J E Newell; R E Bell; G W Cates; G M Martin
Journal:  Can Med Assoc J       Date:  1962-06-09       Impact factor: 8.262

10.  Results of continuous monitoring of the performance of rubella virus IgG and hepatitis B virus surface antibody assays using trueness controls in a multicenter trial.

Authors:  Tamara Kruk; Sam Ratnam; Jutta Preiksaitis; Allan Lau; Todd Hatchette; Greg Horsman; Paul Van Caeseele; Brian Timmons; Graham Tipples
Journal:  Clin Vaccine Immunol       Date:  2012-08-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.